Jacobio Pharma to Present Data of Glecirasib in Combination with JAB-3312 at the 2023 ESMO Conference
/PRNewswire/ -- Jacobio Pharma (1167.HK), a clinical-stage oncology company focusing on undruggable targets, is pleased to announce today that the company will...
United States Jacobio Pharma Andrea Wang Gillam Sasia Congress European Society For Medical Oncology Proffered Paper
Source: prnewswire.com